13 filings
8-K
EOLS
Evolus Inc
12 Nov 19
Entry into a Material Definitive Agreement
4:16pm
8-K
EOLS
Evolus Inc
4 Nov 19
Evolus Reports Third Quarter 2019 Financial Results and Provides Business Update
7:01am
8-K
EOLS
Evolus Inc
12 Aug 19
Evolus Reports Second Quarter 2019 Financial Results
7:02am
8-K
EOLS
Evolus Inc
16 Jul 19
Evolus Expands Board of Directors with Appointment of Independent Directors
4:47pm
8-K
EOLS
Evolus Inc
12 Jun 19
Submission of Matters to a Vote of Security Holders
9:14am
8-K
bm78xo37 ta6y50nh
10 Jun 19
Evolus Provides Update on Nuceiva™ Marketing Authorization Application in Europe
9:49am
8-K
zys2anieh23php3aaa
21 May 19
Entry into a Material Definitive Agreement
4:39pm
8-K
xe2s0m6z220b40u70jlk
8 May 19
Regulation FD Disclosure
8:50am
8-K
f4f0q
30 Apr 19
Evolus Reports First Quarter 2019 Financial Results
4:03pm
8-K
yz4ycl
26 Apr 19
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
9:01am
8-K
j6o2yt
1 Apr 19
Evolus Provides Regulatory Update on Nuceiva™ in the European Union
9:05am
8-K
gvxecmx
18 Mar 19
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
4:05pm
8-K
oqn25oaar8
4 Jan 19
Regulation FD Disclosure
12:00am
- Prev
- 1
- Next